The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study.

Michael Millward, C. House, D. Bowtell, L. Webster, I.N. Olver, M. Gore, M. Copeman, K. Lynch, A. Yap, Y. Wang, P.S. Cohen, J. Zalcberg

    Research output: Contribution to journal › Article › peer-review

    55 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study.'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science